Citius Pharmaceuticals (CTXR)
(Delayed Data from NSDQ)
$0.71 USD
0.00 (-0.28%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.72 +0.02 (2.13%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Citius Pharmaceuticals, Inc falls in the month of September.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -32.54 | -33.64 | -23.05 | -17.55 | -15.56 |
Depreciation/Amortization & Depletion | 0.19 | 0.18 | 0.16 | 0.15 | 0.00 |
Net Change from Assets/Liabilities | -4.01 | 0.24 | -2.72 | -0.87 | 2.20 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.29 | 4.86 | 1.36 | 1.33 | 0.93 |
Net Cash From Operating Activities | -29.06 | -28.36 | -24.25 | -16.93 | -12.44 |
Property & Equipment | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -40.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | -40.01 | 0.00 | 0.00 |
Uses of Funds
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 13.83 | 0.00 | 102.19 | 22.73 | 11.15 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.16 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -0.17 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 18.45 | 0.00 | 0.00 |
Net Cash from Financing Activities | 13.83 | 0.00 | 120.47 | 22.90 | 11.15 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -15.23 | -28.36 | 56.21 | 5.97 | -1.29 |
Cash at Beginning of Period | 41.71 | 70.07 | 13.86 | 7.89 | 9.18 |
Cash at End of Period | 26.48 | 41.71 | 70.07 | 13.86 | 7.89 |
Diluted Net EPS | -0.22 | -0.23 | -0.23 | -0.45 | -0.77 |
Fiscal Year End for Citius Pharmaceuticals, Inc falls in the month of September.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -9.23 | -32.54 | -22.60 | -14.12 |
Depreciation/Amortization & Depletion | NA | 0.05 | 0.19 | 0.14 | 0.10 |
Net Change from Assets/Liabilities | NA | -0.23 | -4.01 | -3.88 | -1.41 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 3.28 | 7.29 | 4.07 | 2.76 |
Net Cash From Operating Activities | NA | -6.14 | -29.06 | -22.26 | -12.68 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 13.83 | 13.83 | 0.03 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.00 | 13.83 | 13.83 | 0.03 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -6.14 | -15.23 | -8.43 | -12.65 |
Cash at Beginning of Period | NA | 26.48 | 41.71 | 41.71 | 41.71 |
Cash at End of Period | NA | 20.35 | 26.48 | 33.28 | 29.07 |
Diluted Net EPS | NA | -0.06 | -0.07 | -0.06 | -0.07 |